Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Robert K. who wrote (13789)	6/6/2000 12:10:00 AM
From: Bluegreen	Read Replies (1) \| Respond to of 17367

LOL!!!! Well, I hope to buy at two a share but now wonder if Xoma can retest the 16 area based on Psoriasis trial alone. Did you see Thomson again today??? What do you think will happen if Baxter announces new trial indications??? What happens when everyone realizes how close the end of the year is and Psoriasis trial is over if goes as planned? Six months goes by pretty fast. I realize a follow up period afterwards BUT anticipation might play a big role by then.